OR4X1
geneOn this page
Summary
OR4X1 (olfactory receptor family 4 subfamily X member 1, HGNC:14854) is a protein-coding gene on chromosome 11p11.2, encoding Olfactory receptor 4X1 (Q8NH49). Odorant receptor.
Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. This olfactory receptor gene is a segregating pseudogene, where some individuals have an allele that encodes a functional olfactory receptor, while other individuals have an allele encoding a protein that is predicted to be non-functional.
Source: NCBI Gene 390113 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 58 total
- MANE Select transcript:
NM_001004726
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:14854 |
| Approved symbol | OR4X1 |
| Name | olfactory receptor family 4 subfamily X member 1 |
| Location | 11p11.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000176567 |
| Ensembl biotype | protein_coding |
| Entrez | 390113 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000320048
RefSeq mRNA: 1 — MANE Select: NM_001004726
NM_001004726
CCDS: CCDS31487
Canonical transcript exons
ENST00000320048 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001260566 | 48263861 | 48264778 |
Expression profiles
Bgee: expression breadth not_expressed, 0 present calls, max score 37.20.
Top tissues by expression
132 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| sural nerve | UBERON:0015488 | 36.13 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.04 | gold quality |
| liver | UBERON:0002107 | 28.33 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| leukocyte | CL:0000738 | 27.53 | gold quality |
| monocyte | CL:0000576 | 27.52 | gold quality |
| tonsil | UBERON:0002372 | 27.05 | gold quality |
| urinary bladder | UBERON:0001255 | 26.89 | gold quality |
| islet of Langerhans | UBERON:0000006 | 26.55 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
| blood | UBERON:0000178 | 26.03 | gold quality |
| gall bladder | UBERON:0002110 | 25.98 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 25.89 | gold quality |
| placenta | UBERON:0001987 | 25.81 | gold quality |
| calcaneal tendon | UBERON:0003701 | 25.03 | gold quality |
| muscle of leg | UBERON:0001383 | 24.87 | gold quality |
| primary visual cortex | UBERON:0002436 | 24.61 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 24.08 | gold quality |
| pancreas | UBERON:0001264 | 24.04 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.82 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 2)
- study identified novel nSNP in OR4X1 gene (rs10838851, Tyr273Ter*), which is significantly associated with FEV1.0/FVC value in pulmonary function test in a Japanese population (PMID:17964544)
- OR4X1A>T (rs10838851) is not associated with recurrent pregnancy loss in Korean women. (PMID:30203366)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Or4x5 | ENSMUSG00000082574 |
| rattus_norvegicus | Or4x5 | ENSRNOG00000054245 |
Paralogs (130): OR1I1 (ENSG00000094661), OR12D3 (ENSG00000112462), OR7A10 (ENSG00000127515), OR7C2 (ENSG00000127529), OR7C1 (ENSG00000127530), OR1E2 (ENSG00000127780), OR1J1 (ENSG00000136834), OR1L4 (ENSG00000136939), OR4D1 (ENSG00000141194), OR4K1 (ENSG00000155249), OR3A3 (ENSG00000159961), OR7G1 (ENSG00000161807), OR1Q1 (ENSG00000165202), OR1K1 (ENSG00000165204), OR4K2 (ENSG00000165762), OR4D6 (ENSG00000166884), OR1F1 (ENSG00000168124), OR4K14 (ENSG00000169484), OR4K15 (ENSG00000169488), OR7G3 (ENSG00000170920), OR7G2 (ENSG00000170923), OR1M1 (ENSG00000170929), OR4D5 (ENSG00000171014), OR1L6 (ENSG00000171459), OR1L3 (ENSG00000171481), OR1L8 (ENSG00000171496), OR1N2 (ENSG00000171501), OR1N1 (ENSG00000171505), OR2AT4 (ENSG00000171561), OR1A1 (ENSG00000172146), OR1A2 (ENSG00000172150), OR4C11 (ENSG00000172188), OR4X2 (ENSG00000172208), OR4D9 (ENSG00000172742), OR10K1 (ENSG00000173285), OR1L1 (ENSG00000173679), OR7D4 (ENSG00000174667), OR4S2 (ENSG00000174982), OR4B1 (ENSG00000175619), OR4D11 (ENSG00000176200)
Protein
Protein identifiers
Olfactory receptor 4X1 — Q8NH49 (reviewed: Q8NH49)
Alternative names: Olfactory receptor OR11-104
All UniProt accessions (1): Q8NH49
UniProt curated annotations — full annotation on UniProt →
Function. Odorant receptor.
Subcellular location. Cell membrane.
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (1): NP_001004726* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR000725 | Olfact_rcpt | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
| IPR050427 | Olfactory_Receptors | Family |
Pfam: PF13853
UniProt features (24 total): topological domain 8, transmembrane region 7, sequence variant 5, glycosylation site 2, chain 1, disulfide bond 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NH49-F1 | 88.10 | 0.53 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (1): 95–187
Glycosylation sites (2): 6, 18
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9752946 | Expression and translocation of olfactory receptors |
MSigDB gene sets: 17 (showing top):
GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, KEGG_OLFACTORY_TRANSDUCTION, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, GOMF_OLFACTORY_RECEPTOR_ACTIVITY, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_SENSORY_PERCEPTION_OF_SMELL, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION, ZNF768_TARGET_GENES, REACTOME_OLFACTORY_SIGNALING_PATHWAY, REACTOME_SENSORY_PERCEPTION, GOBP_DETECTION_OF_CHEMICAL_STIMULUS, GOMF_MOLECULAR_TRANSDUCER_ACTIVITY
GO Biological Process (4): signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186), sensory perception of smell (GO:0007608), detection of chemical stimulus involved in sensory perception of smell (GO:0050911)
GO Molecular Function (2): G protein-coupled receptor activity (GO:0004930), olfactory receptor activity (GO:0004984)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Olfactory Signaling Pathway | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transmembrane signaling receptor activity | 2 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| sensory perception of chemical stimulus | 1 |
| sensory perception of smell | 1 |
| detection of chemical stimulus involved in sensory perception | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of chemical stimulus involved in sensory perception of smell | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
326 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OR4X1 | C1orf167 | Q5SNV9 | 603 |
| OR4X1 | MAGEB16 | A2A368 | 470 |
| OR4X1 | PRSS54 | Q6PEW0 | 452 |
| OR4X1 | OR2C1 | O95371 | 407 |
| OR4X1 | OR1J2 | Q8NGS2 | 398 |
| OR4X1 | DNPEP | Q9ULA0 | 392 |
| OR4X1 | OR2L13 | Q8N349 | 379 |
| OR4X1 | SLC22A24 | Q8N4F4 | 371 |
| OR4X1 | PCDH20 | Q8N6Y1 | 367 |
| OR4X1 | MRGPRF | Q96AM1 | 366 |
| OR4X1 | ZNF117 | Q03924 | 364 |
| OR4X1 | GPR20 | Q99678 | 356 |
| OR4X1 | SH3TC2 | Q8TF17 | 353 |
| OR4X1 | DRC11 | Q86XH1 | 325 |
| OR4X1 | GPR25 | O00155 | 318 |
IntAct
0 interactions, top by confidence:
BioGRID (1): OR4X1 (Affinity Capture-MS)
ESM2 similar proteins: A0A096LPK9, A0A0X1KG70, A6NHA9, A6NMZ5, P0C604, P0C623, P0C645, P0DN82, P58180, P58182, Q15615, Q60881, Q6IF82, Q8IXE1, Q8N0Y3, Q8NGA8, Q8NGB4, Q8NGB6, Q8NGC2, Q8NGC3, Q8NGD0, Q8NGD1, Q8NGD2, Q8NGD5, Q8NGE8, Q8NGF4, Q8NGF8, Q8NGF9, Q8NGI4, Q8NGI6, Q8NGJ0, Q8NGJ1, Q8NGL6, Q8NGM1, Q8NGN0, Q8NGN8, Q8NGX5, Q8NH05, Q8NH42, Q8NH49
Diamond homologs: A0A096LPK9, A0A0X1KG70, A6NHA9, A6NMZ5, O60412, O76099, O95013, P0C604, P0C623, P0C645, P0DN82, P23270, P23275, P58173, P58180, P58182, Q15615, Q60878, Q60881, Q60888, Q6IEV9, Q6IEY1, Q6IF82, Q7TQQ0, Q8IXE1, Q8N0Y3, Q8N628, Q8NGA8, Q8NGB2, Q8NGB4, Q8NGB6, Q8NGB8, Q8NGB9, Q8NGC2, Q8NGC3, Q8NGC4, Q8NGC6, Q8NGD0, Q8NGD1, Q8NGD2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
58 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 50 |
| Likely benign | 8 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
201 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:48264278:G:GA | donor_gain | 0.9100 |
| 11:48264292:G:T | donor_gain | 0.8600 |
| 11:48264122:A:T | donor_gain | 0.8400 |
| 11:48264291:GGA:G | donor_gain | 0.8100 |
| 11:48264277:T:TA | donor_gain | 0.7900 |
| 11:48264287:G:GG | donor_gain | 0.7300 |
| 11:48264175:T:TA | acceptor_gain | 0.7100 |
| 11:48264206:A:AG | donor_gain | 0.6900 |
| 11:48264271:A:T | donor_gain | 0.6900 |
| 11:48264292:G:GT | donor_gain | 0.6800 |
| 11:48264286:C:CG | donor_gain | 0.6700 |
| 11:48263919:G:GG | donor_gain | 0.6200 |
| 11:48264121:G:GT | donor_gain | 0.5500 |
| 11:48264293:A:T | donor_gain | 0.5500 |
| 11:48263918:A:AG | donor_gain | 0.5400 |
| 11:48264178:T:TA | acceptor_gain | 0.5400 |
| 11:48264273:T:G | donor_gain | 0.5400 |
| 11:48264393:A:AG | donor_gain | 0.5300 |
| 11:48264719:TTCA:T | acceptor_loss | 0.5300 |
| 11:48264720:TCA:T | acceptor_loss | 0.5300 |
| 11:48264721:CAG:C | acceptor_loss | 0.5300 |
| 11:48264220:C:G | donor_gain | 0.5200 |
| 11:48264718:CTTCA:C | acceptor_loss | 0.5200 |
| 11:48264591:T:G | donor_gain | 0.5100 |
| 11:48264403:A:AG | acceptor_gain | 0.5000 |
| 11:48264404:G:GG | acceptor_gain | 0.5000 |
| 11:48264590:GTT:G | donor_gain | 0.5000 |
| 11:48264723:GGA:G | acceptor_gain | 0.5000 |
| 11:48264770:G:GG | donor_gain | 0.5000 |
| 11:48264583:T:G | donor_gain | 0.4700 |
AlphaMissense
2029 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:48264356:T:C | F166L | 0.799 |
| 11:48264358:C:A | F166L | 0.799 |
| 11:48264358:C:G | F166L | 0.799 |
| 11:48264158:T:C | F100L | 0.689 |
| 11:48264160:T:A | F100L | 0.689 |
| 11:48264160:T:G | F100L | 0.689 |
| 11:48263945:T:C | F29L | 0.662 |
| 11:48263947:T:A | F29L | 0.662 |
| 11:48263947:T:G | F29L | 0.662 |
| 11:48264386:T:C | F176L | 0.653 |
| 11:48264388:C:A | F176L | 0.653 |
| 11:48264388:C:G | F176L | 0.653 |
| 11:48264602:T:C | F248L | 0.632 |
| 11:48264604:C:A | F248L | 0.632 |
| 11:48264604:C:G | F248L | 0.632 |
| 11:48264605:T:C | F249L | 0.615 |
| 11:48264607:C:A | F249L | 0.615 |
| 11:48264607:C:G | F249L | 0.615 |
| 11:48264674:T:C | F272L | 0.605 |
| 11:48264676:T:A | F272L | 0.605 |
| 11:48264676:T:G | F272L | 0.605 |
| 11:48264035:T:C | F59L | 0.596 |
| 11:48264037:C:A | F59L | 0.596 |
| 11:48264037:C:G | F59L | 0.596 |
dbSNP variants (sampled 300 via entrez): RS1001400194 (11:48265063 G>A), RS1001972306 (11:48263765 A>G), RS1002400928 (11:48264053 T>C), RS1002725930 (11:48263404 C>A,G), RS1003645221 (11:48264766 A>C), RS1004270117 (11:48263684 A>G), RS1004392910 (11:48263429 G>A), RS1004530255 (11:48262540 G>T), RS1005285469 (11:48262518 G>A), RS1006202790 (11:48263695 T>C), RS1008642871 (11:48261879 G>A,T), RS1009742735 (11:48264267 A>C), RS1010333530 (11:48263147 A>G), RS1010422371 (11:48264392 G>T), RS1010958440 (11:48265122 A>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST009685_10 | Hypertension | 7.000000e-09 |
| GCST010244_341 | Triglyceride levels | 3.000000e-08 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004530 | triglyceride measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| pentanal | decreases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Cadmium | decreases expression | 1 |
| Valproic Acid | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): hypertensive disorder